Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Eukaryotic Gene Expression
Fator do impacto: 1.841 FI de cinco anos: 1.927 SJR: 0.627 SNIP: 0.516 CiteScore™: 1.96

ISSN Imprimir: 1045-4403
ISSN On-line: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2017019244
pages 183-195

Role of lncRNAs as Novel Biomarkers and Therapeutic Targets in Ovarian Cancer

Lu-lu Fu
Reproductive Medical Center, Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun, Jilin, China
Chun-jin Li
College of Animal Sciences, Jilin Provincial Key Laboratory of Animal Embryo Engineering, Jilin University, Changchun, China
Ying Xu
Reproductive Medical Center, Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun, Jilin, China
Ling-yun Li
Department of Obstetrics and Gynecology, the Second Hospital of Jilin University, Changchun, China
Xu Zhou
College of Animal Sciences, Jilin Provincial Key Laboratory of Animal Embryo Engineering, Jilin University, Changchun, China
Dan-dan Li
Reproductive Medical Center, Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun, Jilin, China
Shu-xiong Chen
College of Animal Sciences, Jilin University, Changchun, China
Feng-ge Wang
College of Animal Sciences, Jilin University, Changchun, China
Xue-ying Zhang
Department of Obstetrics and Gynecology, the Second Hospital of Jilin University, Changchun, China
Lian-wen Zheng
Reproductive Medical Center, Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun, Jilin, China

RESUMO

Ovarian cancer (OC) is the leading cause of death among all gynecological malignancies in the world and its underlying mechanism is still unclear. Compared with research on microRNAs, research on long non-coding RNAs (lncRNAs) is still in its infancy. Studies in recent years have demonstrated that lncRNAs exhibit multiple biological functions in various stages of OC development. In this review, we conclude that lncRNAs are closely involved in the pathogenesis of OC. The expression of lncRNAs indicates the early diagnosis, prognosis, and response to chemotherapy of OC. An attractive approach to treatment of OC is lncRNA small interfering RNA or acting as a plasmid targeting the expression of toxic genes, which is a novel step toward a major breakthrough in the treatment of human OC. E2-regulated lncRNA and its polymorphism, methylation, are also involved in OC. Further research efforts are needed before fully identifying, characterizing, and elucidating the actual functions of lncRNAs in OC at the molecular level and putting them into clinical practice.


Articles with similar content:

Traditional Concepts and Future Avenues of Glucocorticoid Action in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis Therapy
Critical Reviews™ in Immunology, Vol.29, 2009, issue 3
Fred Luhder, Holger Reichardt
Point Mutations in the AML1/RUNX1 Gene Associated with Myelodysplastic Syndrome
Critical Reviews™ in Eukaryotic Gene Expression, Vol.15, 2005, issue 3
Yuka Harada, Hironori Harada
YY1 Is an Inducer of Cancer Metastasis
Critical Reviews™ in Oncogenesis, Vol.22, 2017, issue 1-2
Guangchao Sui, Dangdang Li, Wenmeng Wang
Homeobox Gene Involvement in Normal Hematopoiesis and in the Pathogenesis of Childhood Leukemias
Critical Reviews™ in Oncogenesis, Vol.22, 2017, issue 3-4
Vassilis Zoumpourlis, Ioannis Christodoulou, Maria Adamaki, Maria Goulielmaki, Spiros Vlahopoulos
Circular RNAs and Exosomes: The New Frontier of Cancer Diagnosis
Forum on Immunopathological Diseases and Therapeutics, Vol.6, 2015, issue 3-4
Rosalba Giugno, Flavia Scoyni